Announcements Trials
Browse Landscape

Phase

Phase 1 130Phase 1/2 60Phase 2 57Phase NA 39Phase 3 22Phase 2/3 6Phase 4 4Phase EARLY_PHASE1 1

Status

Completed 3Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1FED 1

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 53Classical hematology 21Genitourinary 14Gastrointestinal 13Breast 9Other hematologic neoplasm 8Thoracic 5Other 5Plasma cell 4Lymphoid 4Gynecologic 4Dermatologic 4CNS 4Sarcoma 3NET 3Endocrine 3Myeloid 2Head & Neck 2

Conditions

Keratosis, Actinic 46Melanoma 27Skin Neoplasms 14Carcinoma, Basal Cell 9Lymphoma, T-Cell, Cutaneous 8Neoplasm Metastasis 5Mycosis Fungoides 5Lung Neoplasms 5Keratosis 5Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Carcinoma 3Breast Neoplasms 3Uveal Melanoma 2Skin Diseases 2Sezary Syndrome 2Prostatic Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Squamous Cell 2Carcinoma, Renal Cell 2Brain Neoplasms 2Waldenstrom Macroglobulinemia 1Subcutaneous panniculitis-like T-cell lymphoma 1Squamous Cell Carcinoma of Head and Neck 1Skin Substitutes 1Seroma 1Renal Transplant Patients at High-risk for Skin Cancer 1Psoriasis 1Pituitary Neoplasms 1Pituitary ACTH Hypersecretion 1

Interventions

pasireotide 1Sevoflurane 1Propofol 1Isoflurane 1Ipilimumab 1Fluorouracil 1Desflurane 1Cabergoline 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Neoplasms × Dermatologic × Clear all
NCT01794793 2024-10-01

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

RECORDATI GROUP

Phase 4 Completed
337 enrolled 8 charts
DermatologicEndocrineGenitourinaryNET

Acromegaly, Dumping Syndrome, Melanoma, Neoplasms, Pituitary Neoplasms, Prostatic Neoplasms, Neuroendocrine Tumors, Pituitary ACTH Hypersecretion

NCT02068196 2023-03-24

Ipi4

Oslo University Hospital

Phase 4 Active not recruiting
150 enrolled
Dermatologic

Melanoma, Neoplasms

NCT04074460 2022-06-09

VAPOR-C

Peter MacCallum Cancer Centre, Australia

Phase 4 Completed
169 enrolled
BreastDermatologicGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Colonic Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Prostatic Neoplasms

NCT00847912 2021-06-11

VAKCCT

VA Office of Research and Development

Phase 4 Completed
954 enrolled 11 charts
Dermatologic

Carcinoma, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Neoplasms, Neoplasms by Site, Skin Diseases, Skin Neoplasms, Neoplasms, Basal Cell, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡